Hi. I found this forum by google and this is my first time posting thread here. Now I meet a problem in ChIP-seq. There is a sharp peak around TSS region in my Input samples. Although I have heard that the TSS region might be more sensitivity to sonication, my Input sample give so sharp peak around TSS region. Have anyone met this problem too? Why?
-
-
You should post this in the epigenetics forum but the answer is open chromatin sonicates more efficiently. Check out FAIRE-seq
The question is how to minimize this effect.--------------
Ethan -
Are you sure that it's a peak at the TSS, rather than a trough before? We saw this in a number of different samples and it turned out that the major cause (although there may be others) was a loss of mappability in promoters containing CpG islands. If we separated out our transcripts into those whose promoter contained CpG islands, and those which didn't then we saw very different shaped profiles.Comment
-
Thank you for your answer and literature. It seems that sonication quality is important for ChIP-seq and the natural enrichment around TSS is hard to avoid.Originally posted by ETHANol View PostYou should post this in the epigenetics forum but the answer is open chromatin sonicates more efficiently. Check out FAIRE-seq
The question is how to minimize this effect.Comment
-
Senior Member: In my samples, it is a peak/enrichment around TSS and a trough around TES. I did twice ChIP-seq: one is not so sharp, but another one is very sharp and affect my decision on the ChIP lane.
Yeah, I also saw trough aroudn TSS in "Input" of other people's samples. Your explanation for trough around TSS seems to be a good answer for such phenomenon. Thanks a lot!Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment